Evidence map›Paper›PMID 42619303›Full record

ArticleHeadache2026

The diagnostic order of migraine-depression comorbidity associates with physical, mental, and social disability.

Daniel Baksa, Nora Eszlari, Dora Torok, Tamas Nagy, Gabor Hullam, Peter Petschner, Gyorgy Bagdy, Gabriella Juhasz

Abstract read
In one paragraph

Article in Headache, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel BaksaDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.ORCID https://orcid.org/0000-0002-7826-9179
Nora EszlariDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Dora TorokDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Tamas NagyDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Gabor HullamDepartment of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary.
Peter PetschnerDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Gyorgy BagdyDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Gabriella JuhaszDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.

Funding

Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group)Hungarian Brain Research Program 2017-1.2.1-NKP-2017-00002Hungarian Brain Research Program 3.0 NAP2022-I-4/2022Hungarian National Research, Development, and Innovation Office K 143391Hungarian National Research, Development, and Innovation Office PD146014Janos Bolyai Research Scholarship of the Hungarian Academy of SciencesJapan Society for the Promotion of Science (Postdoctoral Fellowships for Research in Japan, standard program) P20809Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, financed under the TKP2021-EGA funding scheme TKP2021-EGA-25National Research, Development, and Innovation Fund of Hungary TKP2021-EGA-02National Research, Development and Innovation Office, Hungary under the frame of ERA PerMed 2019-2.1.7-ERA-NET-2020-00005National Research, Development and Innovation Office, Hungary under the frame of ERA PerMed ERAPERMED2019-108New National Excellence Program of the Ministry for Innovation and Technology from the source of the National National Research, Development and Innovation Fund ÚNKP-21-4-I-SE-15PhD scholarship from Doctoral School of Mental Health Sciences, Semmelweis University, HungaryPhD scholarship from Doctoral School of Pharmaceutical Sciences, Semmelweis University, HungaryThematic Excellence Programme (Tématerületi Kiválósági Program) of the Ministry for Innovation and Technology in Hungary, within the framework of the Neurology and Translational Biotechnology thematic programmes of the Semmelweis University 2020-4.1.1.-TKP2020
6 · The paper itself

Abstract

OBJECTIVES/

backgroundThere is a known bidirectional association between migraine and depression; however, potential effects of the diagnostic trajectory of the diseases are not known. Therefore, we investigated the association of the diagnostic order of migraine and depression with the physical and mental health status of groups with different disease trajectories.

methodsA sample of the UK Biobank was used (n = 327,234; 51.2% female, median age: 58 years) in our cross-sectional study. Based on ICD-10 codes from electronic health record, the following groups were compared: first migraine, then depression (M-D, n = 2036), first depression, then migraine (D-M, n = 1217), only migraine (M, n = 13,318), only depression (D, n = 33,831), and controls (C, n = 276,832). Data covered general descriptive data, socioeconomic status, lifestyle and health, social support, and mental health, collected mostly between 2006 and 2010.

resultsBonferroni-corrected significant results (p < 0.001) emerged between the groups, adjusted for sex. D-M patients showed the highest level of sleeping problems (odds ratio [OR] = 3.26, 95% confidence interval [CI]: 2.72-3.92), neuroticism (β = 3.26, 95% CI: 3.09-3.44), stress (OR = 3.68, 95% CI: 3.19-4.25), the worst rated overall health (OR = 22.93, 95% CI: 17.72-29.68), and the highest Townsend Deprivation Index (β = 0.76, 95% CI: 0.59-0.93). The D-M and M-D patients shared the highest body mass index (β = 1.57, 95% CI: 1.31-1.83; 1.3, 95% CI: 1.09-1.5, respectively) and the lowest physical activity (OR = 0.55, 95% CI: 0.47-0.64; 0.59, 95% CI: 0.53-0.67, respectively). The D patients reported the lowest level of education (OR = 0.71, 95% CI: 0.68-0.73) and income (OR = 0.29, 95% CI: 0.27-0.31), and two comorbid groups showed similarly low values.

conclusionOur study suggests that the diagnostic order is an important feature of migraine-depression comorbidity by revealing that the depression diagnosed first associates with a stronger physical, mental, and social disability even among comorbid cases and this needs specific attention by clinicians.

Indexed as

DepressionMigraine DisordersPersons with DisabilitiesAdultAgedComorbidityCross-Sectional StudiesFemaleHealth StatusHumansMaleMiddle AgedUnited Kingdomdepressiondiagnostic ordermigraineneuroticismsocioeconomic statusstress

Identifiers

PMID42619303
PMCPMC13653250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.